Although more than 13 million Medicare beneficiaries met the BMI thresholds for obesity or overweight based on diagnosis data in 2023, the analysis shows that a smaller group 9.7 million beneficiaries were enrolled in Part D and met the clinical criteria for the Medicare-GLP-1 Bridge, and an even smaller subset 3.8 million met all of the eligibility criteria
Currently two of the drugs Zepbound for obesity and Mounjaro for Type 2 diabetes can't legally be compounded, but the FDA said it will turn a blind eye to the practice for now while it evaluates whether it was right to end the shortage earlier this fall
While no global settlements have been finalized in MDL 3094, which now encompasses 2,190 pending cases as of August 2025, these estimates reflect careful analysis of comparable pharmaceutical litigation patterns and the severity of injuries being reported
To complement your nutritional efforts and provide immediate support, consider incorporating our [GLP-1 Daily Support] supplement
Avoid Harsh Products: Avoid scrubs and chemical exfoliants during the healing period
Refreshing and energizing BOMBBAR drink is packed with vitamins
